Fighting Cancer around the World: A Framework for Action.

cancer diagnostics genomics global health care liquid biopsy next-generation sequencing patients personalized medicine policy framework reimbursement

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
25 Oct 2022
Historique:
received: 29 07 2022
revised: 11 10 2022
accepted: 21 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 12 11 2022
Statut: epublish

Résumé

Tackling cancer is a major challenge right on the global level. Europe is only the tip of an iceberg of cancer around the world. Prosperous developed countries share the same problems besetting Europe-and the countries and regions with fewer resources and less propitious conditions are in many cases struggling often heroically against a growing tide of disease. This paper offers a view on these geographically wider, but essentially similar, challenges, and on the prospects for and barriers to better results in this ceaseless battle. A series of panels have been organized by the European Alliance for Personalised Medicine (EAPM) to identify different aspects of cancer care around the globe. There is significant diversity in key issues such as NGS, RWE, molecular diagnostics, and reimbursement in different regions. In all, it leads to disparities in access and diagnostics, patients' engagement, and efforts for a better understanding of cancer.

Identifiants

pubmed: 36360466
pii: healthcare10112125
doi: 10.3390/healthcare10112125
pmc: PMC9690702
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Pers Med. 2022 Jan 08;12(1):
pubmed: 35055387
Cell. 2019 May 2;177(4):1080
pubmed: 31051100
East Mediterr Health J. 2020 Jun 24;26(6):638-640
pubmed: 32621496
Cancer Epidemiol. 2012 Oct;36(5):e271-8
pubmed: 22621842
Health Aff (Millwood). 2018 May;37(5):780-785
pubmed: 29733732
Biomed Hub. 2020 May 27;5(2):15-67
pubmed: 32775335
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
BMC Med Genomics. 2018 Oct 26;11(1):94
pubmed: 30367635
Pulm Ther. 2021 Dec;7(2):295-308
pubmed: 34089169
Lancet Oncol. 2021 Nov;22(11):e474-e487
pubmed: 34735817
BMC Public Health. 2021 Feb 26;21(1):410
pubmed: 33637056
BMJ Glob Health. 2021 Feb;6(2):
pubmed: 33574068
Eur J Cancer Care (Engl). 2018 Mar;27(2):e12844
pubmed: 29575266
Genomics. 2020 Jan;112(1):721-728
pubmed: 31078717
Public Health Genomics. 2021;24(3-4):99-109
pubmed: 33730737
Am Soc Clin Oncol Educ Book. 2021 Mar;41:1-8
pubmed: 34010049
Genome Med. 2020 Jan 14;12(1):8
pubmed: 31937368
Ecancermedicalscience. 2019 Apr 03;13:920
pubmed: 31281417
J Family Community Med. 2020 Sep-Dec;27(3):208-211
pubmed: 33354152
Value Health Reg Issues. 2012 Dec;1(2):223-227
pubmed: 29702904
Eur J Cancer. 2021 Jun;150:95-98
pubmed: 33892410
Nat Med. 2022 Apr;28(4):658-665
pubmed: 35440717
Mol Oncol. 2021 Jul;15(7):1750-1758
pubmed: 34053182
J Pers Med. 2021 Sep 08;11(9):
pubmed: 34575676
Annu Rev Genomics Hum Genet. 2008;9:403-33
pubmed: 18593304
Biomed Hub. 2017 Nov 21;2(Suppl 1):63-71
pubmed: 31988936
BMJ Open. 2021 Apr 1;11(4):e043641
pubmed: 33795302
Saudi Med J. 2018 Dec;39(12):1259-1262
pubmed: 30520511
Curationis. 2019 May 29;42(1):e1-e9
pubmed: 31170800
F1000Res. 2018 Jan 25;7:111
pubmed: 30026923
Biomed Hub. 2020 Sep 14;5(3):182-223
pubmed: 33564664
Biology (Basel). 2021 Jun 15;10(6):
pubmed: 34203649
World J Surg Oncol. 2018 Mar 22;16(1):63
pubmed: 29566711
BMC Cancer. 2015 Sep 03;15:613
pubmed: 26335225
J Glob Oncol. 2018 Sep;4:1-10
pubmed: 30241252
Ecancermedicalscience. 2020 Jan 06;14:997
pubmed: 32153652
Dis Model Mech. 2017 Apr 1;10(4):349-352
pubmed: 28381596
Biomed Hub. 2017 Nov 21;2(Suppl 1):55-62
pubmed: 31988935
Int J Cancer. 2012 Jan 15;130(2):245-50
pubmed: 21796634
Lancet Oncol. 2019 Jan;20(1):20-23
pubmed: 30614460
Asian Pac J Cancer Prev. 2016;17(7):3173-7
pubmed: 27509947
Int J Equity Health. 2018 Mar 22;17(1):37
pubmed: 29566721
Eur J Breast Health. 2018 Nov 21;15(1):18-25
pubmed: 30816360
Breast. 2020 Dec;54:155-159
pubmed: 33120081
BMC Palliat Care. 2020 Feb 13;19(1):20
pubmed: 32054480
World J Oncol. 2021 Jun;12(2-3):50-60
pubmed: 34046099
Cells. 2019 Aug 09;8(8):
pubmed: 31404988
JCO Glob Oncol. 2020 Feb;6:190-194
pubmed: 32023125
JCO Clin Cancer Inform. 2020 Jul;4:602-613
pubmed: 32644817
Int J Technol Assess Health Care. 2020 Oct;36(5):474-480
pubmed: 32928330
Public Health Genomics. 2018;21(3-4):101-120
pubmed: 30947224
J Community Genet. 2017 Oct;8(4):255-266
pubmed: 28770442
Global Health. 2020 Oct 14;16(1):98
pubmed: 33054820
Infect Agent Cancer. 2017 Nov 06;12:60
pubmed: 29142588
J Glob Oncol. 2019 May;5:JGO1900031
pubmed: 31050921
Life Sci Soc Policy. 2020 Nov 1;16(1):12
pubmed: 33129349
Gulf J Oncolog. 2020 Jan;1(32):71-87
pubmed: 32342923
Cancer Sci. 2021 Mar;112(3):970-977
pubmed: 33289217
Urol Oncol. 2014 Feb;32(2):187-92
pubmed: 24445286
Biomed Hub. 2017 Nov 21;2(Suppl 1):16-21
pubmed: 31988925
ESMO Open. 2019 Jul 17;4(4):e000483
pubmed: 31423334
J Pharm Policy Pract. 2018 Oct 24;11:25
pubmed: 30386627
Front Oncol. 2021 Apr 15;11:650117
pubmed: 33937056
Braz J Psychiatry. 2020 Aug;42(4):456-457
pubmed: 32401877
Glob Health Action. 2018;11(1):1419033
pubmed: 29336236

Auteurs

Denis Horgan (D)

European Alliance for Personalised Medicine, 1040 Brussels, Belgium.
Department of Molecular and Cellular Engineering, Jacob Institute of Biotechnology and Bioengineering, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India.

Rizwana Mia (R)

Genomics Centre, South African Medical Research Council, Tygerberg, Cape Town 7500, South Africa.

Tosan Erhabor (T)

Medical Laboratory Science Council of Nigeria (MLSCN), Durumi, Abuja 900110, Nigeria.

Yosr Hamdi (Y)

Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis 1002, Tunisia.
Laboratory of Human and Experimental Pathology, Institut Pasteur de Tunis, Tunis 1002, Tunisia.

Collet Dandara (C)

Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Observatory, Cape Town 7925, South Africa.

Jonathan A Lal (JA)

Department of Molecular and Cellular Engineering, Jacob Institute of Biotechnology and Bioengineering, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India.
Institute for Public Health Genomics, Department of Genetics and Cell Biology, GROW School of Oncology and Developmental Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6211 LK Maastricht, The Netherlands.

Joel Fokom Domgue (JF)

Departments of Epidemiology, and Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Centre, Houston, TX 77030, USA.
Department of Obstetrics and Gynecology, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Yaounde VF7W+4M9, Cameroon.

Oladimeji Ewumi (O)

Freelance Health Care, Life Sciences, Medical Artificial Intelligence Content Writer, Lagos 100253, Nigeria.

Teresia Nyawira (T)

National Commission for Science, Technology and Innovation in Kenya (NACOSTI), Nairobi 00100, Kenya.

Salomé Meyer (S)

Cancer Alliance, Cape Town 7700, South Africa.

Dominique Kondji (D)

Health & Development Communication, Building Capacities for Better Health in Africa, Yaounde P.O. Box 2032, Cameroon.

Ngiambudulu M Francisco (NM)

Grupo de Investigação Microbiana e Imunológica, Instituto Nacional de Investigação em Saúde (National Institute for Health Research), Luanda 3635, Angola.

Sadakatsu Ikeda (S)

Department of Precision Cancer Medicine, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.

Chai Chuah (C)

Singularity University, P.O. Box 165, Gold Coast, QLD 4227, Australia.

Roselle De Guzman (R)

Oncology and Pain Management Section, Manila Central University-Filemon D. Tanchoco Medical Foundation Hospital, Caloocan 1400, Philippines.

Anupriya Paul (A)

Department of Mathematics and Statistics, Faculty of Science, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India.

Krishna Reddy Nallamalla (K)

ACCESS Health India, Hyderabad 500086, India.

Woong-Yang Park (WY)

Samsung Genome Institute, Samsung Medical Centre, Sungkyunkwan University, Seoul 06351, Korea.

Vijay Tripathi (V)

Department of Molecular and Cellular Engineering, Jacob Institute of Biotechnology and Bioengineering, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India.

Ravikant Tripathi (R)

Ministry of Labor, Health Department Government of India, New Delhi 110001, India.

Amber Johns (A)

Garvan Institute of Medical Research and the Kinghorn Cancer Centre, Cancer Division, Sydney, NSW 2010, Australia.

Mohan P Singh (MP)

Centre of Biotechnology, University of Allahabad, Allahabad 211002, India.

Maude E Phipps (ME)

Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya 47500, Selangor, Malaysia.

France Dube (F)

Astra Zeneca, 1800 Concord Pike, Wilmington, DE 19803, USA.

Kate Whittaker (K)

Cancer Council Australia, Sydney, NSW 2000, Australia.

Deborah Mukherji (D)

Global Health Institute, American University of Beirut, Beirut VFXP+7QF, Lebanon.
Department of Hematology/Oncology, American University of Beirut Medical Centre, Beirut P.O. Box 11-0236, Lebanon.

Hadi Mohamad Abu Rasheed (HMA)

Qatar Cancer Society, Doha 22944, Qatar.

Marta Kozaric (M)

European Alliance for Personalised Medicine, 1040 Brussels, Belgium.

Joseph A Pinto (JA)

Centre for Basic and Translational Research, Auna Ideas, Lima 15036, Peru.

Stephen Doral Stefani (S)

UNIMED RS, Porto Alegre 90040-180, Brazil.

Federico Augustovski (F)

Health Technology Assessment and Health Economics, Department of the Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires C1056ABH, Argentina.

Maria Eugenia Aponte Rueda (ME)

Venezuelan Breast Cancer Research and Education Foundation, Caracas 1060, Venezuela.

Ricardo Fujita Alarcon (R)

Centro de Genética y Biología Molecular, Universidad de San Martín de Porres, Lima 15024, Peru.

Hugo A Barrera-Saldana (HA)

Innbiogem SC/Vitagenesis SA at National Laboratory for Services of Research, Development, and Innovation for the Pharma and Biotech Industries (LANSEIDI) of CONACyT Vitaxentrum Group, Monterrey 64630, Mexico.
Schools of Medicine and Biology, Autonomous University of Nuevo Leon, Monterrey 66451, Mexico.

Classifications MeSH